Loading...

Home
Stock
ROIV

ROIV News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Forecast Technical Valuation Financials Earnings Should I Buy News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
All US Stocks

AI Strategies

AI Stock Picker
Swing Trading
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Monitor News

Compare

TradingView
SeekingAlpha

ROIV News

Immunovant (IMVT) to Report Q3 2025 Financial Results on February 6, 2026

6 days agoGlobenewswire

Sun Pharmaceutical Evaluates $10 Billion Acquisition of Organon & Co.

Jan 20 2026Benzinga

Nvidia Director Sells $44.3 Million in Shares as Stock Rises 5%

Dec 23 2025CNBC

Insider at Roivant Sciences Offloads Shares Valued at $37,723,200, Recent SEC Filing Reveals

Dec 18 2025Yahoo Finance

Immunovant (IMVT) Rises 14.0% Following $550 Million Equity Raise Backed by Roivant for IMVT-1402 - Is the Bullish Outlook Still Valid?

Dec 15 2025Yahoo Finance

Roivant Indicates Significant Progress in Pipeline with Faster Timelines

Dec 11 2025Benzinga

ROIV Surpasses Average Analyst Price Target

Nov 11 2025NASDAQ.COM

Will the Decline in Revenue Growth at Roivant Sciences (ROIV) Impact Its Future Innovation Narrative?

Nov 11 2025Yahoo Finance

ROIV Events

an image of No data

No data

ROIV Monitor News

Roivant Sciences reaches 5-day high amid market fluctuations

Roivant Sciences Ltd sees stock drop amid market strength

Roivant Sciences Ltd reaches 52-week high amid sector rotation

Roivant Sciences outlines accelerated timelines for key drug developments

Roivant Sciences Ltd reaches a 52-week high amid sector rotation.

ROIV Earnings Analysis

Roivant Sciences Earnings & Drug Discoveries Update- Intellectia AI™

Roivant Sciences Shows Resilience with Strategic Advancements - Intellectia AI™

Roivant Reports Second Quarter Financial Results for 2024

People Also Watch